Related Experiment Video

Updated: Aug 13, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

Leukotriene B4 and inflammatory disease

R M McMillan1, S J Foster

  • 1Imperial Chemical Industries, PLC, Bioscience I Department, Mereside, Alderley Park, Macclesfield, Cheshire, U.K.

Agents and Actions
|June 1, 1988
PubMed

Insights

Leukotriene B4 (LTB4) and C5a may synergize to recruit inflammatory cells, challenging the view that LTB4 is redundant. This suggests novel therapeutic strategies targeting inflammatory pathways.

Area of Science:

  • Immunology
  • Inflammation Research

Background:

  • Polymorphonuclear leukocytes (PMNL) are key in acute inflammation.
  • Leukotriene B4 (LTB4), a 5-lipoxygenase product, is implicated in inflammatory responses.
  • Existing evidence for LTB4's pro-inflammatory role and 5-lipoxygenase inhibitor efficacy is largely circumstantial.

Purpose of the Study:

  • To challenge the notion that C5a compensates for LTB4 absence in PMNL recruitment.
  • To propose a synergistic interaction between LTB4 and C5a in mediating inflammation.
  • To explore the distinct roles of LTB4 and C5a in inflammatory processes.

Main Methods:

  • Review of recent experimental and clinical data.
  • Analysis of chemotactic factor roles in PMNL infiltration.

Main Results:

  • LTB4 and C5a do not simply have overlapping functions.
  • LTB4 and C5a may act at different sites, leading to synergistic PMNL recruitment.
  • Experimental and clinical data support a distinct, potentially synergistic, role for LTB4.

Conclusions:

  • LTB4's role in inflammation is not redundant with C5a.
  • LTB4 and C5a likely synergize in PMNL recruitment.
  • This interaction offers new insights into anti-inflammatory drug development targeting the 5-lipoxygenase pathway.

More Related Videos

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...